-+ 0.00%
-+ 0.00%
-+ 0.00%

Reported Earlier, Arcutis Expands ZORYVE Label With FDA Approval For Once-Daily Steroid-Free Plaque Psoriasis Treatment In Young Children

Benzinga·06/30/2026 07:56:28
Listen to the news
  • ZORYVE cream 0.3% is the first once-daily, non-steroidal therapy approved for children with plaque psoriasis as young as 2 years of age
  • ZORYVE cream 0.3% is safe, effective, and well-tolerated for use anywhere on the body with no restrictions on duration of use
  • Seventh FDA approval for ZORYVE in four years